# Benjamin Wooden

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/benjamin-wooden/

## Facts

| Field | Value |
| --- | --- |
| Citations | 261 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 7 |
| i10-index | 6 |
| Last Known Institution | Columbia University Irving Medical Center |
| OpenAlex ID | https://openalex.org/A5012320419 |
| ORCID iD | 0000-0003-4286-5005 |
| Works | 16 |

## Researcher papers

- [Using Big Data to Discover Diagnostics and Therapeutics for Gastrointestinal and Liver Diseases](https://scholariq.org/papers/using-big-data-to-discover-diagnostics-and-therapeutics-for-gastrointestinal-and/)
- [Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease](https://scholariq.org/papers/strong-protective-effect-of-the-apol1-p-n264k-variant-against-g2-associated/)
- [Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells](https://scholariq.org/papers/transcriptome-based-repurposing-of-apigenin-as-a-potential-anti-fibrotic-agent/)
- [Complement inhibitors for kidney disease](https://scholariq.org/papers/complement-inhibitors-for-kidney-disease/)
- [Natural History and Clinicopathological Associations of TRPC6-Associated Podocytopathy](https://scholariq.org/papers/natural-history-and-clinicopathological-associations-of-trpc6-associated/)
- [Update on C3 Glomerulopathy](https://scholariq.org/papers/update-on-c3-glomerulopathy/)
- [Podocytopathies](https://scholariq.org/papers/podocytopathies-2/)
- [Prophylactic anticoagulation in patients with nephrotic syndrome in the Cure Glomerulonephropathy (CureGN) cohort](https://scholariq.org/papers/prophylactic-anticoagulation-in-patients-with-nephrotic-syndrome-in-the-cure/)
- [Clinical phenotypes and renal outcomes in PLA2R-associated membranous nephropathy: a multi-center cohort study with unsupervised cluster analysis](https://scholariq.org/papers/clinical-phenotypes-and-renal-outcomes-in-pla2r-associated-membranous/)
- [Strong protective effect of the <i>APOL1</i> p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease](https://scholariq.org/papers/strong-protective-effect-of-the-i-apol1-i-p-n264k-variant-against-g2-associated/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)

## Researcher university

- [Columbia University Irving Medical Center](https://scholariq.org/institutions/columbia-university-irving-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.